Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.090 EUR
198.58 M EUR
1.00 B EUR
1.77 B
About 3SBIO INC
Sector
Industry
CEO
Jing Lou
Website
Headquarters
Shenyang
Founded
1993
FIGI
BBG009CK4G84
3SBio, Inc. operates as an investment holding company, which engages in the development, production, marketing, and sale of biopharmaceutical products. Its products are used in the field of medicine, particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. It operates through the Mainland China and Others geographical segments. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange 3SBIO INC. DL -,00001 stocks are traded under the ticker 83B.
We've gathered analysts' opinions on 3SBIO INC. DL -,00001 future price: according to them, 83B price has a max estimate of 1.18 EUR and a min estimate of 0.74 EUR. Watch 83B chart and read a more detailed 3SBIO INC. DL -,00001 stock forecast: see what analysts think of 3SBIO INC. DL -,00001 and suggest that you do with its stocks.
Yes, you can track 3SBIO INC. DL -,00001 financials in yearly and quarterly reports right on TradingView.
3SBIO INC. DL -,00001 is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
83B earnings for the last half-year are 0.06 EUR per share, whereas the estimation was 0.06 EUR, resulting in a 2.27% surprise. The estimated earnings for the next half-year are 0.05 EUR per share. See more details about 3SBIO INC. DL -,00001 earnings.
3SBIO INC. DL -,00001 revenue for the last half-year amounts to 563.72 M EUR, despite the estimated figure of 558.91 M EUR. In the next half-year revenue is expected to reach 608.23 M EUR.
83B net income for the last half-year is 141.17 M EUR, while the previous report showed 71.26 M EUR of net income which accounts for 98.11% change. Track more 3SBIO INC. DL -,00001 financial stats to get the full picture.
3SBIO INC. DL -,00001 dividend yield was 3.32% in 2023, and payout ratio reached 35.62%. The year before the numbers were 1.20% and 10.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 1, 2024, the company has 5.41 K employees. See our rating of the largest employees — is 3SBIO INC. DL -,00001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 3SBIO INC. DL -,00001 EBITDA is 382.94 M EUR, and current EBITDA margin is 35.01%. See more stats in 3SBIO INC. DL -,00001 financial statements.
Like other stocks, 83B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 3SBIO INC. DL -,00001 stock right from TradingView charts — choose your broker and connect to your account.